Amgen denied judgment against Regeneron's US antitrust claims over cholesterol drug
MLex Summary: Amgen was denied a summary judgment today against US claims accusing it of engaging in an anticompetitive drug bundling scheme over cholesterol reduction drugs. US District Judge Jennifer L....To view the full article, register now.
Already a subscriber? Click here to view full article